Allen Capital Group’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Buy
38,643
+411
+1% +$21.7K 0.17% 105
2026
Q1
$2.01M Sell
38,232
-207
-0.5% -$10.9K 0.18% 98
2025
Q4
$2.03M Buy
38,439
+1,683
+5% +$89.1K 0.19% 98
2025
Q3
$1.95M Sell
36,756
-565
-2% -$29.9K 0.18% 94
2025
Q2
$1.98M Buy
37,321
+4,866
+15% +$256K 0.2% 89
2025
Q1
$1.71M Buy
32,455
+2,848
+10% +$151K 0.19% 88
2024
Q4
$1.56M Buy
29,607
+2,162
+8% +$115K 0.19% 88
2024
Q3
$1.46M Buy
27,445
+14,981
+120% +$792K 0.18% 89
2024
Q2
$660K Buy
12,464
+4,619
+59% +$244K 0.09% 117
2024
Q1
$414K Buy
+7,845
New +$412K 0.06% 140

Other funds holding CLOI

Allen Capital Group's CLOI Position: Q2 2026 in Review

Allen Capital Group increased its VanEck CLO ETF (CLOI) stake by 1.1% in Q2 2026, buying an estimated $21.7K and bringing the position to 38,643 shares worth $2.05M. The position accounts for 0.17% of the portfolio, ranked #105.

Allen Capital Group first reported a position in CLOI in Q1 2024 and has held it in 10 quarters since. 197 funds tracked by Wall St. Rank hold CLOI as of Q2 2026.

  • Allen Capital Group held 38,643 shares of VanEck CLO ETF worth $2.05M as of Q2 2026.
  • Allen Capital Group bought 411 VanEck CLO ETF shares in Q2 2026, an estimated $21.7K.
  • VanEck CLO ETF made up 0.17% of Allen Capital Group's portfolio in Q2 2026, its #105 holding.
  • Allen Capital Group first reported a position in VanEck CLO ETF in Q1 2024 and has held it in 10 quarters since.
  • 197 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q2 2026.

Based on Allen Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.